285 related articles for article (PubMed ID: 18204257)
1. Advances in chemotherapy against advanced or metastatic colorectal cancer.
Omura K
Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
[TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of metastatic colorectal cancer.
Goldberg RM
Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
[TBL] [Abstract][Full Text] [Related]
4. New systemic frontline treatment for metastatic colorectal carcinoma.
Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
[TBL] [Abstract][Full Text] [Related]
5. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
7. Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan.
Miyazaki Y; Harada T; Akase T; Arakawa I; Inoue T
Clin Ther; 2009; 31 Pt 2():2433-41. PubMed ID: 20110051
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of different chemotherapeutical regimens in metastatic colorectal cancer].
Liu TS; Yu YY; Chen YY
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):120-3. PubMed ID: 18344076
[TBL] [Abstract][Full Text] [Related]
9. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
Kelly H; Goldberg RM
J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
[TBL] [Abstract][Full Text] [Related]
10. [IFL].
Yamazaki K; Yoshino T; Boku N
Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478
[TBL] [Abstract][Full Text] [Related]
11. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
Lee JJ; Chu E
Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
[TBL] [Abstract][Full Text] [Related]
12. Is there a third-line therapy for metastatic colorectal cancer?
Grothey A
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S36-8. PubMed ID: 17178284
[TBL] [Abstract][Full Text] [Related]
13. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
[TBL] [Abstract][Full Text] [Related]
15. [A case of metastatic rectal cancer showing a sustained complete response to chemotherapy with FOLFIRI followed by UFT].
Tashima R; Yokoyama S; Yamashita Y; Baba K; Matsuda M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1663-6. PubMed ID: 17940386
[TBL] [Abstract][Full Text] [Related]
16. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
17. Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer.
Grávalos C; Cassinello J; Fernández-Rañada I; Holgado E
Clin Colorectal Cancer; 2007 Nov; 6(10):691-9. PubMed ID: 18039422
[TBL] [Abstract][Full Text] [Related]
18. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
19. First- and second-line therapy of metastatic colorectal cancer.
Terstriep S; Grothey A
Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
Engstrom PF;
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):18S-22S. PubMed ID: 18980548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]